ACTIVE SUBSTANCE / INN

PREDNISOLONE SODIUM PHOSPHATE

Brand name(s): ORAPRED ODT, INFLAMASE FORTE, INFLAMASE MILD, HYDELTRASOL, ORAPRED, SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE, METRETON
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA083358
ANDA080751
ACTIVE SUBSTANCE
Prednisolone Sodium Phosphate
REGULATORS
FDA
SPONSORS / MAH
EPIC PHARMA LLC, BAUSCH AND LOMB, MERCK
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PREDNISOLONE SODIUM PHOSPHATEANDA083358EPIC PHARMA LLCDiscontinued
ORAPRED ODTNDA021959ADVANZ PHARMAPrescription
PREDNISOLONE SODIUM PHOSPHATEANDA040070BAUSCH AND LOMBPrescription
ORAPREDANDA075117CONCORDIA PHARMS INCDiscontinued
INFLAMASE MILDANDA080751NOVARTISDiscontinued
INFLAMASE FORTEANDA080751NOVARTISDiscontinued
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATEANDA074449BAUSCH AND LOMBPrescription
METRETONANDA083834SCHERINGDiscontinued
PEDIAPREDNDA019157SETON PHARMPrescription
HYDELTRASOLNDA011028MERCKDiscontinued

FULL INTELLIGENCE ON PREDNISOLONE SODIUM PHOSPHATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →